Human trials to begin for Alzheimer's nasal vaccine
After 20 years of studies, researchers will begin the first human trial for a nasal vaccine aimed at preventing and slowing Alzheimer's disease. Sixteen participants at Boston's Brigham and Women's Hospital will receive two doses of the vaccine one week apart. CBS Boston's Zinnia Maldonado has more.
